Kyoto, Japan

Ryota Kotaka

This inventor holds 1 USPTO granted patent. Top assignee: Kaken Pharmaceutical Company, Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryota Kotaka. Retrieved from https://idiyas.com/inventor/ryota-kotaka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ryota Kotaka

Introduction

Ryota Kotaka is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific diseases.

Latest Patents

Kotaka holds a patent for a heteroaromatic amide derivative and a medicament containing the same. This innovative compound demonstrates high efficacy for diseases associated with Nav1.7 and is represented by the general formula (I). His work in this area showcases his commitment to advancing medical treatments.

Career Highlights

Ryota Kotaka is affiliated with Kaken Pharmaceutical Company, Ltd., where he continues to contribute to pharmaceutical research and development. His expertise in medicinal chemistry has positioned him as a valuable asset in the industry.

Collaborations

Kotaka has collaborated with esteemed colleagues, including Issei Akahoshi and Yoshitake Sumikawa. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Ryota Kotaka's contributions to medicinal chemistry and his innovative patent reflect his dedication to improving healthcare solutions. His work continues to inspire advancements in the pharmaceutical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…